We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

12 hedge funds and large institutions have $199K invested in Biolase, Inc. in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

36% less capital invested

Capital invested by funds: $312K → $199K (-$113K)

52% less funds holding

Funds holding: 25 → 12 (-13)

76% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 17

Holders
12
Holders Change
-13
Holders Change %
-52%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
1
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$271K
2
BlackRock
BlackRock
New York
+$126K
3
ZF
Zhang Financial
Michigan
+$55.1K
4
Walleye Capital
Walleye Capital
New York
+$14.4K
5
TRCT
Tower Research Capital (TRC)
New York
+$8.15K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$67K
2
APP
Avantax Planning Partners
Iowa
-$38.5K
3
Millennium Management
Millennium Management
New York
-$28.8K
4
TSS
Two Sigma Securities
New York
-$11.4K
5
PCM
Perkins Capital Management
Minnesota
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$95.4K +$271K +51,281 New
BlackRock
2
BlackRock
New York
$46.5K +$126K +23,834 +2,013%
Walleye Capital
3
Walleye Capital
New York
$31.5K +$14.4K +2,729 +19%
ZF
4
Zhang Financial
Michigan
$22.5K +$55.1K +10,429 +632%
TRCT
5
Tower Research Capital (TRC)
New York
$3K +$8.15K +1,541 +2,111%
Osaic Holdings
6
Osaic Holdings
Arizona
$93 -$11 -2 -4%
Bank of America
7
Bank of America
North Carolina
$76 +$217 +41 New
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Quebec, Canada
$69 +$196 +37 New
Morgan Stanley
9
Morgan Stanley
New York
$32 +$37 +7 +70%
Wells Fargo
10
Wells Fargo
California
$15 +$32 +6 +300%
IA
11
IFP Advisors
Florida
$6 +$423 +80 +8,000%
HNB
12
Huntington National Bank
Ohio
$1 +$5 +1 New
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
– -$67K -9,617 Closed
APP
14
Avantax Planning Partners
Iowa
– -$38.5K -5,441 Closed
Millennium Management
15
Millennium Management
New York
– -$28.8K -4,068 Closed
TSS
16
Two Sigma Securities
New York
– -$11.4K -1,609 Closed
PCM
17
Perkins Capital Management
Minnesota
– -$11K -1,572 Closed
Vanguard Group
18
Vanguard Group
Pennsylvania
– -$6.67K -944 Closed
Commonwealth Equity Services
19
Commonwealth Equity Services
Massachusetts
– -$5K -757 Closed
Geode Capital Management
20
Geode Capital Management
Massachusetts
– -$3.88K -549 Closed
HF
21
HRT Financial
New York
– -$3K -518 Closed
VF
22
Virtu Financial
New York
– -$3K -471 Closed
UBS Group
23
UBS Group
Switzerland
– -$2.89K -407 Closed
CSS
24
Cubist Systematic Strategies
Connecticut
– -$2.53K -358 Closed
Bank of Montreal
25
Bank of Montreal
Ontario, Canada
– -$2.85K -340 Closed
1
2

BIOL Hedge Fund Activity: Q3 2023 in Review

12 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q3 2023, worth a combined $199K — down 36% from $312K a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of BIOL and 4 opened new positions — a net loss of 13 holders — while 1 trimmed existing stakes and 7 added.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $271K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $67K sold.

  • 12 institutional investors held Biolase, Inc. (BIOL) as of Q3 2023, down from 25 in Q2 2023.
  • Funds reported $199K of Biolase, Inc. stock for Q3 2023, down 36% quarter-over-quarter.
  • 4 funds opened new Biolase, Inc. positions in Q3 2023 and 17 closed out, a net change of -13 holders.
  • The largest Biolase, Inc. buyer in Q3 2023 was Anson Funds Management, an estimated $271K added.
  • The largest Biolase, Inc. seller in Q3 2023 was Acadian Asset Management, an estimated $67K sold.

Based on aggregated 13F filings for Q3 2023.